Type 2 diabetes mellitus (T2DM) accounts for nearly 90% of diabetes mellitus (DM) worldwide and is a chronic metabolic disorder characterized by hyperglycemia which is triggered by dysfunction of insulin secretion or insulin resistance (Tiwari et al., 2014; Manaithiya et al., 2021). This evidence concerns the gene INS and Hyperglycemia.